ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,261Medicare Part D Prescriptions Filled, Including Refills

Rank: 276 out of 2343

$901K Total Retail Price of All Prescriptions

Rank: 176 out of 2343

336 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,967 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 512 425 1 8
LISINOPRIL 414 351 2 3
AMLODIPINE BESYLATE 406 351 3 5
SIMVASTATIN 373 279 4 1
FUROSEMIDE 371 299 5 6
LEVOTHYROXINE SODIUM 364 324 6 2
OMEPRAZOLE 334 291 7 4
CITALOPRAM HBR 329 286 8 17
METOPROLOL TARTRATE 298 257 9 7
ZOLPIDEM TARTRATE 248 234 10 24
TRAMADOL HCL 216 203 11 25
CARVEDILOL 150 133 12 27
OXYCODONE-ACETAMINOPHEN 150 108 S2 12 49
ALENDRONATE SODIUM 147 138 14 28
DONEPEZIL HCL 143 143 15 21
METOPROLOL SUCCINATE 138 121 16 14
IPRATROPIUM-ALBUTEROL 129 122 17 99
CRESTOR 129 111 17 30
METFORMIN HCL 124 100 19 9
QUETIAPINE FUMARATE 122 113 20 77
PANTOPRAZOLE SODIUM 120 106 21 22
HYDROCODONE-ACETAMINOPHEN 120 82 S3 21 13
PRAVASTATIN SODIUM 119 114 23 15
NAMENDA 118 118 24 36
GLIMEPIRIDE 115 103 25 45
ADVAIR DISKUS 114 93 26 34
DIOVAN 110 100 27 23
JANUVIA 109 103 28 50
NYSTOP 107 89 29 196
METOCLOPRAMIDE HCL 104 74 30 168
AZITHROMYCIN 90 80 31 39
KLOR-CON M10 86 73 32 107
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 63 33 42
PEN NEEDLE 81 61 34 119
PREDNISONE 79 68 35 37
GABAPENTIN 79 73 35 16
ROPINIROLE HCL 79 36 35 124
ATORVASTATIN CALCIUM 79 71 35 10
NEXIUM 79 65 35 33
HYDROCHLOROTHIAZIDE 78 77 40 11
SERTRALINE HCL 77 59 41 20
MELOXICAM 76 54 42 68
TAMSULOSIN HCL 74 69 43 29
ALLOPURINOL 73 61 44 31
CYMBALTA 72 60 45 74
MIRTAZAPINE 72 53 45 41
DIGOXIN 70 70 47 35
KLOR-CON M20 69 65 48 44
LANTUS SOLOSTAR 69 55 48 101
CLOPIDOGREL 68 58 50 26
FENOFIBRATE 67 54 51 94
CARBIDOPA-LEVODOPA 67 67 51 85
SPIRIVA 67 61 51 48
FENTANYL 66 31 S2 54 69
TRAMADOL HCL-ACETAMINOPHEN 66 33 54 199
TRILIPIX 66 52 54 214
FLUTICASONE PROPIONATE 63 63 57 46
CELEBREX 62 52 58 71
PRANDIN 61 48 59 140
CYCLOBENZAPRINE HCL 61 50 R 59 109
SPIRONOLACTONE 59 52 61 65
CIPROFLOXACIN HCL 59 37 61 72
HUMALOG 57 33 63 131
CEPHALEXIN 57 41 63 111
PAROXETINE HCL 56 27 65 66
VERAPAMIL ER 56 43 65 95
CLONIDINE HCL 54 44 67 70
CEFPODOXIME PROXETIL 53 45 68 570
LATANOPROST 53 43 68 200
BUSPIRONE HCL 51 29 70 146
AGGRENOX 51 51 70 174
QUINAPRIL HCL 50 39 72 73
LEVOFLOXACIN 50 41 72 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.